News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtables
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Antimicrobial Stewardship|
Bench to Bedside With SIDP|
C. difficile |
Clinical Corner|
Fungal Infections|
Hepatitis|
RSV: A New Era in Prevention
Advertisement

MelANIE T. MAHONEY, MPH, PHARMD STUDENT

Advertisement

Articles by MelANIE T. MAHONEY, MPH, PHARMD STUDENT

What's New From the CLSI Subcommittee on Antimicrobial Susceptibility Testing

ByMelANIE T. MAHONEY, MPH, PHARMD STUDENT,Elizabeth B. Hirsch, PharmD, RPH, FIDSA
October 9th 2019

Updates include novel and revised breakpoints for azithromycin, polymyxins, daptomycin, and cefiderocol.

Advertisement

Latest Updated Articles

  • What's New From the CLSI Subcommittee on Antimicrobial Susceptibility Testing
    What's New From the CLSI Subcommittee on Antimicrobial Susceptibility Testing

    Published: October 9th 2019 | Updated:



Advertisement
Advertisement

Trending on Contagion Live

1

Opioid Use Linked to Nearly Double the Risk of C difficile Infection

2

FDA Approves GSK’s Gepotidacin for Gonorrhea

3

FDA Plans to Review Already Approved RSV Immunizations

4

‘Complicating the Decision-Making’ for the Universal Birth Dose of the Hepatitis B Vaccine

5

FDA Grants First Approval Under Priority Voucher Program, Fast-Tracking Antibiotic to Strengthen US Drug Supply Chain

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us